Applying Artificial Intelligence to Optimize Early-stage Hepatocellular Carcinoma Treatment Based on Multi-modal Image

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-12-01

Study Completion Date

2025-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study intends to establish two prognostic models based on contrast-enhanced ultrasound (CEUS) and dynamic enhanced magnetic resonance (DE-MRI) multimodal images: prognostic model of liver cancer patients after hepatectomy and prognostic model of liver cancer patients after radiofrequency ablation. Combined with artificial intelligence imaging omics, traditional imaging omics and clinical information, to predict and compare the prognosis of two different treatment methods for early liver cancer, so as to realize the individual selection of treatment methods for early liver cancer patients

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Image Driven Hepatocellular Carcinoma Invasiveness Evaluation Research

NCT06559761

Hepatocellular Carcinoma Stage III

RECRUITING

Survival Analysis of Surgical Resection Versus Observation in Patients With Initially uHCC Achieving CR After Systemic Therapy

NCT07290764

Hepatocellular Carcinoma

ENROLLING_BY_INVITATION

Impact of Three-dimensional Visualization on Operation Strategy and Complications for Complex Hepatic Carcinoma

NCT03132740

Hepatic Carcinoma

UNKNOWN

Microwave Ablation Versus Laparoscopic Hepatectomy for 3-5cm Hepatocellular Carcinoma

NCT05796700

Overall Survival Progression-free Survival Cost

COMPLETED NA

The Construction and Effect Verification of a Deep Learning-based Automated Semantic Segmentation Model for Medical Imaging

NCT06864702

Artificial Intelligence (AI) Deep Learning Laparoscopic Surgery

ENROLLING_BY_INVITATION NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hepatocellular Carcinoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SR

CEUS and CEMRI

Intervention Type OTHER

contrast-enhanced ultrasound and contrast-enhanced MRI examination

RFA

CEUS and CEMRI

Intervention Type OTHER

contrast-enhanced ultrasound and contrast-enhanced MRI examination

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CEUS and CEMRI

contrast-enhanced ultrasound and contrast-enhanced MRI examination

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Primary single hepatocellular carcinoma confirmed by histology or cytology, with a maximum diameter ≤5.0 cm;

* Good liver function, Child-Pugh grade A;

* No serious dysfunction of heart, lung, kidney and other important organs ④ Liver resection or radiofrequency ablation was performed in our hospital, and the study protocol and follow-up procedure were followed.

Exclusion Criteria

* Patients who cannot perform DCE-MRI examination due to metal implants in the body ② Patients who had received other treatment before DCE-MRI or CEUS;

* Invisible lesions, diffuse lesions or poor DCE-MRI/CEUS image quality under CEUS; ④ Drug abuse, clinical or psychological or social factors that make informed consent or study implementation affected.

Eligible Sex

ALL

Accepts Healthy Volunteers

No